Research shows that women are often underrepresented in HIV clinical trials. In fact, astudy recently published in the Journal of Acquired Immune Deficiency Syndromes found that less than a quarter of clinical trial participants for antiretroviral medications are women. Women’s participation in HIV clinical trials is crucial to ensure findings help improve the health of both women and men living with HIV.Aid United Policy Action Center
Sara Looby, PhD, ANP-BC and Markella Zanni, MD, REPRIEVE Trial Investigators
Read the full article here.